Greg Kilby currently serves as the Senior Director of Applications & Market Development at MOBILion Systems, Inc., where he leverages his extensive background in analytical chemistry to drive innovative solutions in the biopharma and pharmaceutical sectors. With two decades of experience, Greg has honed his...
Greg Kilby currently serves as the Senior Director of Applications & Market Development at MOBILion Systems, Inc., where he leverages his extensive background in analytical chemistry to drive innovative solutions in the biopharma and pharmaceutical sectors. With two decades of experience, Greg has honed his expertise in proteomics, metabolomics, and assay development, positioning him as a key figure in the advancement of analytical platforms that address complex biological questions.
In his role, Greg is responsible for conducting comprehensive market diligence and coordinating the company’s application and market expansion strategies. He collaborates closely with cross-functional teams, including Business, Sales, and Marketing, to ensure that MOBILion’s cutting-edge technologies are effectively positioned to meet the evolving needs of the industry. His leadership in strategic planning and execution has been instrumental in identifying new opportunities for growth and enhancing the company’s competitive edge.
Greg’s proficiency in protein purification, chemistry, and biomarker discovery allows him to provide invaluable insights into the development of novel analytical methods that can streamline workflows and improve data quality. His commitment to Good Laboratory Practices (GLP) ensures that all projects adhere to the highest standards of quality and compliance, further solidifying MOBILion's reputation as a leader in the field. As he continues to drive application development and market initiatives, Greg remains dedicated to advancing the frontiers of analytical science, ultimately contributing to the success of biopharma innovations that can transform patient outcomes.
